Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • elondin
    Junior Member
    • Jan 2011
    • 2

    #1

    SNP calling

    Hi all,

    I have a question regarding determing if an identified SNP would be a heterozygote. When looking at the total number of reads for a specific base, what percentage of those reads need to differ from the reference to be considered a heterozygote. For example, if a base has 50 a coverage of 50 reads, but 25% of them differ from the reference would this be called as a heterozygote? Essentially, at what proportion of calls that differ from the reference is a homozygote vs. heterozygote?

    Any thoughts?
    thanks
  • flxlex
    Moderator
    • Nov 2008
    • 412

    #2
    The difference from the reference is in a way irrelevant here, I feel. What matters is the amount of reads that show a difference for the organism you sampled. If around 50% shows one base, and the rest shows the other, then the organism you sequenced is a heterozygote at that position, right? How much deviation you can have from 50/50, I don't know, but there will be some spread...

    Comment

    • husamia
      Member
      • Apr 2010
      • 66

      #3
      you stated "When looking at the total number of reads for a specific base, what percentage of those reads need to differ from the reference to be considered a heterozygote." I say "When looking at the total number of reads for a specific base, what percentage of those reads need to differ from the reference to be considered a variant?" I have seen cutoff of 15% and 20%. We're only talking about diploid organisms of course. Its a good question, since you have to take into account only true reads.
      Last edited by husamia; 01-24-2011, 08:33 AM.

      Comment

      • krobison
        Senior Member
        • Nov 2007
        • 734

        #4
        A number of the SNP callers have attempted to answer this question (with the additional complication that your bases may not all be called to the same confidence) using Bayesian principles; if you really want to understand it, you should study those papers.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...